Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fries

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
British Journal of Pharmacology|July 1, 2008
Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissuesD J Behm, J J McAtee, J W Dodson, et al.
Circulation Research|May 13, 2026
Atherosclerosis Profiling Reveals BHLHE40 as a Candidate Modulator of VSMCChinyere O Ibikunle, Enrique J Garcia, Chenyi Xue, et al.
Plos One|April 7, 2022
A multi-stage process to develop quality indicators for community-based palliative care using interRAI dataDawn M Guthrie, Nicole Williams, Cheryl Beach, et al.
Plos One|December 19, 2024
Correction: A multi-stage process to develop quality indicators for community-based palliative care using interRAI dataDawn M Guthrie, Nicole Williams, Cheryl Beach, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophoreDavid G Washburn, Dennis A Holt, Jason Dodson, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonistsJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolaseReema K Thalji, Jeff J McAtee, Svetlana Belyanskaya, et al.
Journal of Medicinal Chemistry|January 5, 2007
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitorsKrista B Goodman, Haifeng Cui, Sarah E Dowdell, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profilesJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
British Journal of Pharmacology|July 1, 2008
Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissuesD J Behm, J J McAtee, J W Dodson, et al.
Circulation Research|May 13, 2026
Atherosclerosis Profiling Reveals BHLHE40 as a Candidate Modulator of VSMCChinyere O Ibikunle, Enrique J Garcia, Chenyi Xue, et al.
Plos One|April 7, 2022
A multi-stage process to develop quality indicators for community-based palliative care using interRAI dataDawn M Guthrie, Nicole Williams, Cheryl Beach, et al.
Plos One|December 19, 2024
Correction: A multi-stage process to develop quality indicators for community-based palliative care using interRAI dataDawn M Guthrie, Nicole Williams, Cheryl Beach, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophoreDavid G Washburn, Dennis A Holt, Jason Dodson, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonistsJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolaseReema K Thalji, Jeff J McAtee, Svetlana Belyanskaya, et al.
Journal of Medicinal Chemistry|January 5, 2007
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitorsKrista B Goodman, Haifeng Cui, Sarah E Dowdell, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profilesJohn J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Pageof 26